BCS Private Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.23M Sell
10,698
-217
-2% -$129K 1.97% 11
2026
Q2
$5.48M Buy
10,915
+860
+9% +$413K 1.65% 16
2026
Q1
$4.95M Sell
10,055
-196
-2% -$106K 1.5% 16
2025
Q4
$5.94M Sell
10,251
-590
-5% -$334K 2.03% 11
2025
Q3
$5.26M Buy
10,841
+215
+2% +$100K 1.88% 13
2025
Q2
$4.31M Buy
+10,626
New +$4.44M 1.62% 16

Other funds holding TMO

BCS Private Wealth Management's TMO Position: Q3 2026 in Review

BCS Private Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 2% in Q3 2026, selling an estimated $129K and leaving 10,698 shares worth $7.23M. The position accounts for 1.97% of the portfolio, ranked #11.

BCS Private Wealth Management first reported a position in TMO in Q2 2025 and has held it in 6 quarters since. 2,806 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • BCS Private Wealth Management held 10,698 shares of Thermo Fisher Scientific worth $7.23M as of Q3 2026.
  • BCS Private Wealth Management sold 217 Thermo Fisher Scientific shares in Q3 2026, an estimated $129K.
  • Thermo Fisher Scientific made up 1.97% of BCS Private Wealth Management's portfolio in Q3 2026, its #11 holding.
  • BCS Private Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 6 quarters since.
  • 2,806 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on BCS Private Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.